Your nurse will screen for contraindications, allergies, and current medications before administration
References: Wu, L., Zhou, M., Li, T., Dong, N., Yi, L., Zhang, Q., & Mi, M
July 14, 2024: Ozempic Lawsuit Intensifies with New Studies Linking Drug to Vision Loss The Ozempic blindness and vision loss lawsuit is full steam ahead following the July 2024 study indicating huge increases in the risk of NAION for users of semaglutide
Diffusion-weighted MRI (dMRI) and mean diffusivity (MD) were used to compare white matter microstructure between the asthmatic and control groups
Br J Pharmacol (2010) 159:495501
However, to date, extensive RCTs have shown no correlation between specific GLP-1 RAs and increased cancer risk